A revised ordinance will ban consumer products containing cannabis-derived CBN starting in June. Only patients with specific conditions, such as intractable diseases without alternative treatments, will be allowed to use them.
The Japan Times reports that under a revised ordinance from the Ministry of Health, Labour and Welfare (MHLW), consumer products containing CBN—a substance derived from cannabis—will be banned starting in June. Access will be restricted to patients with specific conditions, such as intractable diseases with no alternative treatment options. The article, published on March 19, 2026, lists keywords including drugs, MHLW, CBN, and marijuana. This policy targets consumer products while preserving limited medical applications.
